1Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation(ATRIA) Study. JAMA, 2001, 285:2370-2375.
2Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation ma the risk of death: The Framingharn Heart Study. Circulation, 1998,98: 946 - 952.
3Bruins P, Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C - reactive protein and is associated with postoperative arrhythmia. Circulation, 1997, 96: 3542 - 3548.
4Demellis J, Panaretou M. C - reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol, 2001, 56: 375 - 380.
5Chung MK, Martin DO, Sprecher D, et al. C - reactive protein elevation in patients with atrial arrhythmias. Circulation, 2001,104:2886 - 2891,
6Wazni OM, Martin DO, Marrouche NF, et al, C- Reactive protein level and recurrence of atrial fibrillation after electrical cardioversion, Heart, 2005,12.
7Watanabe T, Takeishi Y, Hirono O, et al. C - Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels, 2005, 20:45 -49.
8Aviles RJ, Martin DO, Apperson - Hansen C, et al. Inflammation as a Risk Factor for Atrial Fibrillation. Circulation, 2003, 108 : 3006 - 3010.
9Psychari SN, Apestolou TS, Sinos L, et al. Relation of elevated C - reactive protein and interleukin- 6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol, 2005, 95:764-767.
10Conway DS, Bug;gins P, Hughes E, et al. Prognostic significance of raised plasma levels of interleukin - 6 and C - reactive protein in atrial fibrillation. Am Heart J, 2004, 148:462-466.
